Add to ORKGTherapeutic strategies that aim to neutralise the important pro-inflammatory cytokine tumour necrosis factor alpha (TNF alpha) have gained considerable prominence in the therapy of chronic inflammatory diseases, notably rheumatoid arthritis and Crohn's disease. This drug focus review will concentrate on the antitumour necrosis factor antibody infliximab (Remicade), which has been approved for the treatment of rheumatoid arthritis and Crohn's disease in both the US and Europe. In addition, infliximab is under investigation for several other indications, mainly inflammatory rheumatic diseases. Clinical trials have been persuasive that infliximab is both safe and effective, and it has been proven to be far superior to the conventional drug the...
A review. The development of inhibitors of Tumor Necrosis Factor (TNF) a, a pro-inflammatory cytoki...
Rheumatoid arthritis (RA) is a chronic inflammatory, autoimmune disease with a prevalence of approxi...
The management of patients with rheumatoid arthritis now focuses on both the relief of symptoms and ...
Therapeutic strategies that aim to neutralise the important pro-inflammatory cytokine tumour necrosi...
Therapeutic strategies that aim to neutralise the important pro-inflammatory cytokine tumour necrosi...
Therapeutic strategies that aim to neutralise the important pro-inflammatory cytokine tumour necrosi...
Since the initial characterization of tumor necrosis factor alpha (TNFalpha), it has become clear th...
ABSTRACTIt is now evident that biological agents targeting on the tumor necrosis factor (TNF) have n...
227 Tumor necrosis factor-alpha (TNF-a.) is an inflammatory cytokine that is important in the inflam...
It is now evident that biological agents targeting on the tumor necrosis factor (TNF) have not only ...
Tumor necrosis factor alpha (TNF alpha) and interleukin-1 (IL-1) are important in mediating inflamma...
The cytokine, tumour necrosis factor-alpha (TNF-alpha) plays a key role in the pathogenesis of many ...
Tumour necrosis factor-alpha (TNF-α) is a pro-inflammatory cytokine produced by many cell types (blo...
The availability of agents that block the biological activity of tumor necrosis factor alpha (TNF al...
The current pharmacotherapy of rheumatoid arthritis (RA) consists of non-steroidal anti inflammatory...
A review. The development of inhibitors of Tumor Necrosis Factor (TNF) a, a pro-inflammatory cytoki...
Rheumatoid arthritis (RA) is a chronic inflammatory, autoimmune disease with a prevalence of approxi...
The management of patients with rheumatoid arthritis now focuses on both the relief of symptoms and ...
Therapeutic strategies that aim to neutralise the important pro-inflammatory cytokine tumour necrosi...
Therapeutic strategies that aim to neutralise the important pro-inflammatory cytokine tumour necrosi...
Therapeutic strategies that aim to neutralise the important pro-inflammatory cytokine tumour necrosi...
Since the initial characterization of tumor necrosis factor alpha (TNFalpha), it has become clear th...
ABSTRACTIt is now evident that biological agents targeting on the tumor necrosis factor (TNF) have n...
227 Tumor necrosis factor-alpha (TNF-a.) is an inflammatory cytokine that is important in the inflam...
It is now evident that biological agents targeting on the tumor necrosis factor (TNF) have not only ...
Tumor necrosis factor alpha (TNF alpha) and interleukin-1 (IL-1) are important in mediating inflamma...
The cytokine, tumour necrosis factor-alpha (TNF-alpha) plays a key role in the pathogenesis of many ...
Tumour necrosis factor-alpha (TNF-α) is a pro-inflammatory cytokine produced by many cell types (blo...
The availability of agents that block the biological activity of tumor necrosis factor alpha (TNF al...
The current pharmacotherapy of rheumatoid arthritis (RA) consists of non-steroidal anti inflammatory...
A review. The development of inhibitors of Tumor Necrosis Factor (TNF) a, a pro-inflammatory cytoki...
Rheumatoid arthritis (RA) is a chronic inflammatory, autoimmune disease with a prevalence of approxi...
The management of patients with rheumatoid arthritis now focuses on both the relief of symptoms and ...